Wednesday September 27th

13.25-13.30 pm - Opening

Welcome and introduction: Pr Eric Deutsch, Director of Gustave Roussy Radiation Oncology Department and INSERM UMR 1030

PRIMER ON CANCER IMMUNOLOGY, RADIATIONS AND IMMUNOTHERAPY

(Educational Session)

 

13.30-15.30 Part I

  • 30-14.00: INNATE IMMUNITY

Tumor-associated macrophages from bench to bedside, Pr Alberto Mantovani, Istituto Clinico Humanitas, IT

  • 00-14.30: ADAPTIVE IMMUNITY

Role of tertiary lymphoid structures in response to anti-cancer immunotherapy, Pr Antoine Italiano, Gustave Roussy, FR

  • 30-15.00: IMMUNOLOGICAL CELL DEATH

Immunological cell death: inducers and enhancers, Pr Guido Kroemer, Cordeliers Research Center, FR

  • 00-15.30: ABSCOPAL EFFECT

Mechanisms of interaction of radiotherapy with immunotherapy, Pr Silvia Formenti, Weill Cornell Medicine, USA

15.30-16.00 Coffee break

 

16.00-18.00 Part II

  • 00-16.30: CLINICAL IMMUNOTHERAPY

How to build on the top of current chemo-radiations and PD-L1 inhibitors? The NSCLC model, Pr Fabrice Barlési, Gustave Roussy, FR

  • 30-17.00: DNA DAMAGE RESPONSE

Modulating DNA damage responses to enhance radiotherapy-immunotherapy combinations, Pr Kevin Harrington, Institute of Cancer Research, UK

  • 00-17.30: RADIO-IMMUNOTHERAPY

Immunogenic cell death driven by radiotherapy – Mechanisms and implications, Dr Lorenzo Galluzzi, Weill Cornell Medicine, USA

MAIN PROGRAM

Keynote Presentation

  • 30-18.15: AI for Cancer Precision Medicine, Pr Fabrice André, Gustave Roussy, FR

18.00-20.00 COCKTAIL POSTER SESSION

Cookie Policy

This website uses cookies that are necessary to its functioning and required to achieve the purposes illustrated in the privacy policy. By accepting this OR scrolling this page OR continuing to browse, you agree to our privacy policy.